/ /

  • linkedin
  • Increase Font
  • Sharebar

    Photoactivation holds promise for keratitis treatment




    When using collagen cross-linking to treat keratoconus, clinicians anesthetize the patient’s cornea, apply 0.1% riboflavin, and expose the cornea to 365 nm ultraviolet light. Free radicals created by this irradiation create new covalent bonds between collagen fibers, which strengthens the cornea.

    More: When is crosslinking appropriate?


    New Call-to-action


    You must be signed in to leave a comment. Registering is fast and free!

    All comments must follow the ModernMedicine Network community rules and terms of use, and will be moderated. ModernMedicine reserves the right to use the comments we receive, in whole or in part,in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

    • No comments available


    View Results